翔宇医疗跌2.02%，成交额9044.51万元，主力资金净流出2053.63万元

Group 1 - The core viewpoint of the news is that Xiangyu Medical's stock has experienced fluctuations, with a recent decline of 2.02% and a year-to-date increase of 25.95% [1] - As of January 16, the stock price is reported at 76.20 yuan per share, with a total market capitalization of 12.192 billion yuan [1] - The company has seen a net outflow of main funds amounting to 20.5363 million yuan, with significant selling pressure from large orders [1] Group 2 - Xiangyu Medical, established on March 20, 2002, specializes in the research, production, and sales of rehabilitation medical devices, with a revenue composition of 67.79% from rehabilitation therapy equipment [2] - The company belongs to the pharmaceutical and biological industry, specifically in the medical device sector, and is involved in various concept sectors including brain-machine interface and robotics [2] - As of September 30, the company reported a revenue of 537 million yuan for the first nine months of 2025, reflecting a year-on-year growth of 6.00%, while the net profit attributable to shareholders decreased by 40.09% to 43.9815 million yuan [2] Group 3 - Since its A-share listing, Xiangyu Medical has distributed a total of 277 million yuan in dividends, with 157 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders increased by 51.24% to 9,531, while the average circulating shares per person decreased by 33.88% to 16,787 shares [2][3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 918,600 shares, an increase of 12,530 shares compared to the previous period [3]